The balance sheet exhibits severe volatility, highlighted by a reported $12.1 billion in total assets for 2026Q1 that appears inconsistent with the firm's historical micro-cap scale.
| Total Current Assets | 10.76B | 3.02B | 5.23M | 2.54M | 4.14M | 8.49M |
| Cash & Short-Term Investments | 10.05B | 2.07B | 4.55M | 1.8M | 3.49M | 8.04M |
| Cash Only | 10.05B | 2.07B | 4.55M | 1.8M | 3.49M | 8.04M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 5.11M | 141.29K | 101.9K | 223.47K | 266.21K | 334.18K |
| Days Sales Outstanding | - | - | 4.96 | 118.9 | 342.13 | 1.11K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 704.03M | 950.29M | 4.11K | 67.86K | 216.89K | 0 |
| Total Non-Current Assets | 1.37B | 2.01B | 2.13M | 2.58M | 3.03M | 1.71M |
| Property, Plant & Equipment | 864.96M | 962.08M | 1.21M | 1.58M | 1.96M | 946.68K |
| Fixed Asset Turnover | 0.00x | - | 6.22x | 0.43x | 0.14x | 0.12x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 334.52M | 316.67M | 246.42K | 210.88K | 219.57K | 97.69K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 167.18M | 727.31M | 678.22K | 789.99K | 848.34K | 668.23K |
| Total Assets | 12.13B | 5.03B | 7.36M | 5.12M | 7.17M | 10.2M |
| Asset Turnover | 0.00x | - | 1.02x | 0.13x | 0.04x | 0.01x |
| Asset Growth % | 205078.68% | 68190.82% | 43.85% | -28.63% | -29.74% | - |
| Total Current Liabilities | 1.55B | 1.07B | 1.38M | 1.6M | 2.22M | 1.21M |
| Accounts Payable | 932.22M | 399.36K | 490.25K | 897.27K | 784.69K | 717.8K |
| Days Payables Outstanding | 250.38K | 321.67 | - | - | - | - |
| Short-Term Debt | 246.59M | 265.89M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 156K | 15K |
| Other Current Liabilities | 370.97M | 801.67M | 32.97K | 145.04K | 27.08K | 43.47K |
| Current Ratio | 6.94x | 2.83x | 3.80x | 1.58x | 1.86x | 7.02x |
| Quick Ratio | 6.94x | 2.83x | 3.80x | 1.58x | 1.86x | 7.02x |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 96.74M | 156.19M | 284.65K | 599.14K | 41.21M | 34.76M |
| Long-Term Debt | 96.74M | 156.19M | 0 | 0 | 6.6M | 992.02K |
| Capital Lease Obligations | 645.64K | 0 | 284.27K | 563.69K | 840.9K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | -156.19K | 381 | 35.45K | 33.76M | 33.77M |
| Total Liabilities | 1.65B | 1.22B | 1.66M | 2.2M | 43.43M | 35.97M |
| Total Debt | 343.33M | 422.08M | 555.51K | 885.95K | 7.73M | 992.02K |
| Net Debt | -9.71B | -1.65B | -4M | -910.04K | 4.24M | -7.05M |
| Debt / Equity | 0.03x | 0.11x | 0.10x | 0.30x | - | - |
| Debt / EBITDA | -30.25x | - | - | - | - | - |
| Net Debt / EBITDA | 855.45x | - | - | - | - | - |
| Interest Coverage | -30.90x | -1441.87x | -735.72x | -66.17x | -41.40x | -132.49x |
| Total Equity | 10.48B | 3.8B | 5.7M | 2.91M | -36.26M | -25.77M |
| Equity Growth % | 237600.37% | 66608.16% | 95.61% | 108.03% | -40.73% | - |
| Book Value per Share | 675.36 | 779.97 | 10.04 | 84.40 | -599.41 | -425.93 |
| Total Shareholders' Equity | 10.48B | 3.8B | 5.7M | 2.91M | -36.26M | -25.77M |
| Common Stock | 1.62M | 1.07K | 763 | 1.21K | 104 | 104 |
| Retained Earnings | -72.45B | -68.52M | -57.57M | -48.6M | -37.31M | -26.63M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Data integrity and liquidity
As reported in financial statements, Azitra's asset base has exhibited extreme volatility, culminating in a reported $12.1 billion figure for 2026Q1 that deviates sharply from historical norms, suggesting significant data integrity concerns that complicate any assessment of the company's long-term financial trajectory or business quality.
The massive fluctuation in total assets and equity suggests that the company's balance sheet is not currently a reliable indicator of operational health. Investors should monitor whether these figures represent genuine capital restructuring or persistent reporting errors that obscure the firm's true financial standing.
Based on Azitra's reported figures, the current ratio has fluctuated wildly, reaching 6.94 in 2026Q1, which stands in stark contrast to the 0.77 ratio observed in 2024Q2, indicating that the company's ability to cover short-term obligations remains highly uncertain and potentially misrepresented in current filings.
The erratic nature of the cash position and current ratio suggests that the company may lack a stable buffer against operational shocks. Without consistent liquidity, the firm remains highly vulnerable to the need for dilutive financing to sustain its ongoing clinical development programs.
According to recent SEC filings, the company's retained earnings have consistently trended downward, reaching a deficit of $72.4 billion in 2026Q1, which highlights the significant erosion of shareholder equity as the firm continues to fund its pre-revenue research and development activities through persistent capital consumption.
The accumulation of massive negative retained earnings underscores the high-risk nature of the company's business model. This trend suggests that shareholder value is being systematically depleted, and future recovery is entirely dependent on the successful clinical validation of its lead therapeutic candidates.
As indicated by the provided data, the reported $10.1 billion cash balance in 2026Q1 is fundamentally inconsistent with the company's micro-cap status, suggesting that the balance sheet may contain material reporting distortions that prevent an accurate evaluation of the firm's actual financial risk and operational runway.
The discrepancy between the reported cash and the company's historical burn rate warrants extreme skepticism from investors. Relying on these headline figures may lead to a fundamental misunderstanding of the company's true solvency and its immediate need for additional capital to continue operations.
Quick answers to the most common questions about buying AZTR stock.
As of 2025, Azitra, Inc. (AZTR) had total assets of $5.03B including $3.02B in current assets.
Azitra, Inc. (AZTR) carries total debt of $422.1M, offset by $2.07B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Azitra, Inc. (AZTR) has total shareholders' equity (book value) of $3.80B ($779.97 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Azitra, Inc. (AZTR) reported a current ratio of 2.83x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.